Stefan Chun

Stefan Chun is a Senior Research Associate in Bioconjugation at Bolt Biotherapeutics, Inc. since December 2021, previously serving as a Research Associate in the same field. Prior experience includes a Research Associate role at Genentech from February 2021 to December 2021 and a Formulation Scientist II position at Thermo Fisher Scientific, where responsibilities included QC production of MS2 phage formulations for COVID-19 testing. Stefan's tenure at Genentech also encompassed roles as a Senior QC Analyst and Bioprocess Technician in upstream cell culture manufacturing between April 2017 and July 2020, with earlier experience as an Engineering Support Intern. Stefan holds a Bachelor’s Degree in Cell/Cellular and Molecular Biology from the University of California, Berkeley, earned in 2016.